JP5722927B2 - チロトロピン受容体の結合対象及びその使用 - Google Patents

チロトロピン受容体の結合対象及びその使用 Download PDF

Info

Publication number
JP5722927B2
JP5722927B2 JP2013007593A JP2013007593A JP5722927B2 JP 5722927 B2 JP5722927 B2 JP 5722927B2 JP 2013007593 A JP2013007593 A JP 2013007593A JP 2013007593 A JP2013007593 A JP 2013007593A JP 5722927 B2 JP5722927 B2 JP 5722927B2
Authority
JP
Japan
Prior art keywords
binding
tsh receptor
tsh
antibody
molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2013007593A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013126987A5 (https=
JP2013126987A (ja
Inventor
サンダース，ジェーン
ファーマニアク，ジャドウィガ
スミス，バーナルド，リース
Original Assignee
アールエスアール リミテッド
アールエスアール リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0315147A external-priority patent/GB0315147D0/en
Application filed by アールエスアール リミテッド, アールエスアール リミテッド filed Critical アールエスアール リミテッド
Publication of JP2013126987A publication Critical patent/JP2013126987A/ja
Publication of JP2013126987A5 publication Critical patent/JP2013126987A5/ja
Application granted granted Critical
Publication of JP5722927B2 publication Critical patent/JP5722927B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2869—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Rehabilitation Therapy (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2013007593A 2002-11-29 2013-01-18 チロトロピン受容体の結合対象及びその使用 Expired - Lifetime JP5722927B2 (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB0227964.4 2002-11-29
GBGB0227964.4A GB0227964D0 (en) 2002-11-29 2002-11-29 Binding partners for the thyrotropin receptor and uses thereof
GBGB0302140.9A GB0302140D0 (en) 2002-11-29 2003-01-29 Binding partners for the thyrotropin receptor and uses thereof
GB0302140.9 2003-01-29
GB0315147A GB0315147D0 (en) 2002-11-29 2003-06-27 Binding partners for the thyrotropin receptor and uses thereof
GB0315147.9 2003-06-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2004570698A Division JP5314234B2 (ja) 2002-11-29 2003-11-28 チロトロピン受容体の結合対象及びその使用

Publications (3)

Publication Number Publication Date
JP2013126987A JP2013126987A (ja) 2013-06-27
JP2013126987A5 JP2013126987A5 (https=) 2013-12-05
JP5722927B2 true JP5722927B2 (ja) 2015-05-27

Family

ID=9948838

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013007593A Expired - Lifetime JP5722927B2 (ja) 2002-11-29 2013-01-18 チロトロピン受容体の結合対象及びその使用

Country Status (5)

Country Link
JP (1) JP5722927B2 (https=)
AT (1) ATE525086T1 (https=)
ES (2) ES2371244T3 (https=)
GB (2) GB0227964D0 (https=)
HU (1) HUE034370T2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5304939B1 (ja) * 2012-05-31 2013-10-02 大日本印刷株式会社 光学積層体、偏光板、偏光板の製造方法、画像表示装置、画像表示装置の製造方法及び画像表示装置の視認性改善方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909661D0 (en) * 1998-06-06 1999-06-23 Rsr Ltd Assays for TSH receptor autoantibodies
EP2383296B1 (en) * 2002-11-29 2017-02-22 Rsr Limited Antibody for the thyrotropin receptor and uses thereof

Also Published As

Publication number Publication date
GB0227964D0 (en) 2003-01-08
ES2371244T3 (es) 2011-12-28
ES2624241T3 (es) 2017-07-13
HUE034370T2 (en) 2018-02-28
GB0302140D0 (en) 2003-03-05
ATE525086T1 (de) 2011-10-15
JP2013126987A (ja) 2013-06-27

Similar Documents

Publication Publication Date Title
JP5314234B2 (ja) チロトロピン受容体の結合対象及びその使用
US12534526B2 (en) NKG2A antibody, preparation method therefor and application thereof
JP7215759B2 (ja) ４－１ｂｂ抗体およびその製造方法と使用
JP5982698B2 (ja) Ｄｌｌ４に特異的に結合する新規モノクローナル抗体及びその用途
US10613099B2 (en) Cell lines expressing surface bound anti-idiotype antibodies against anti-CD22 antibodies and uses thereof
US7943345B2 (en) Methods, systems and reagents for improved immunodetection
US7935793B2 (en) Treatment of inflammatory bowel diseases with anti-IP-10 antibodies
US20140243265A1 (en) Antibodies to modified human igf-1/e peptides
RU2710439C2 (ru) Новое антитело против пресепсина
CN115515984B (zh) 一种抗cd19抗体的抗体及其制备和应用
JP2729159B2 (ja) ヒトグリセンチンのモノクローナル抗体、この抗体を産生するハイブリドーマおよびそれを用いるヒトグリセンチンの定量法
EP1708961B1 (en) Anti-ip-10 antibodies
JP5722927B2 (ja) チロトロピン受容体の結合対象及びその使用
JP2011160696A (ja) 修飾ヒトｉｇｆ−１／ｅペプチドに対する抗体
CN111848799A (zh) 特异性检测抗体及其在制备检测试剂盒中的用途
CN113999306A (zh) 一种获得识别空间构象表位抗体的方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20131018

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140624

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140919

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150224

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150326

R150 Certificate of patent or registration of utility model

Ref document number: 5722927

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term